Medlive Technology Co., Ltd. — Board/Management Information 2011

Aug 10, 2011

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [287 x 29] intentionally omitted <==

HISENSE KELON ELECTRICAL HOLDINGS COMPANY LIMITED 海信科龍電器股份有限公司

(A joint stock limited company incorporated in the People’s Republic of China with limited liability)

(Stock Code: 00921)

ANNOUNCEMENT ON PROPOSED

APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR

Reference is made to the announcement on resignation of an independent non-executive director of Hisense Kelon Electrical Holdings Company Limited (the “Company”) dated 29 July 2011.

In accordance with the relevant laws, regulations and the articles of association of the Company, the board of directors of the Company nominates Mr. Wang Xinyu (“Mr. Wang”) as an independent non-executive director candidate for the seventh session of the board of directors of the Company. Such nomination will be proposed to the extraordinary general meeting of the Company (the “EGM”) for approval (please refer to Note 1 for the biography of Mr. Wang). If Mr. Wang is elected, the term of office will expire at the end of the seventh session of the board of directors of the Company.

The EGM will be held for the shareholders of the Company to consider and, if thought fit, approve, among other matters, the proposed appointment of Mr. Wang as an independent non-executive director of the Company. A notice of the EGM, the proxy form and a circular containing, among other things, details of the proposed appointment of independent non-executive director will be dispatched to the shareholders of the Company on 10 August 2011.

Note 1 ：Mr. Wang Xinyu, aged 40, graduated from the University of International Business and Economics with a bachelor degree in international finance and obtained a M.B.A from the University of Chicago Booth School of Business. He served as the director of MBK Partners from October 2005 to February 2010 and he has acted as the managing director of JP Capital Investment Limited since September 2010. He has acted as the director of Luye Pharma Group Ltd. (listed on the Singapore Stock Exchange) from August 2008 to February 2010.

1

Save as disclosed above, Mr. Wang has not held any directorship in any other listed companies for the past three years nor holds any shares of the Company or any its associated corporations within the meaning of Part XV of the Securities and Futures Ordinance. Mr. Wang does not have any relationship with any directors, senior management, or substantial or controlling shareholders of the Company or its subsidiaries. During his term of office as an independent non-executive director of the Company, Mr. Wang is entitled to an annual emolument of RMB240,000 (before taxation) from the Company as the independent non-executive director. Such emolument was determined by the Remuneration & Evaluation Committee of the Board after taking into consideration of the scale of operation of the Company and the remuneration level of independent non-executive directors of other listed companies. Mr. Wang will stand for election as the independent non-executive director of the Company. If elected, Mr. Wang’s term of office will commence from the date of his appointment at the EGM until the expiry of the term of the seventh session of the board of directors (that is 25 June 2012). It is also intended that Mr. Wang will be appointed as member of the Audit Committee, the Nomination Committee and the Remuneration & Evaluation Committee by the board of directors of the Company after he is elected as the independent non-executive director of the Company.

Save as disclosed above, Mr. Wang confirms that there is no other matter that needs to be disclosed pursuant to Rules 13.51(2)(h) to 13.51(2)(v) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited nor any other matter that needs to be brought to the attention of the shareholders of the Company.

By order of the Board of

Hisense Kelon Electrical Holdings Company Limited

Tang Ye Guo

Chairman

As at the date of this announcement, the Company’s directors are Mr. Tang Ye Guo, Mr. Ren Li Ren, Ms. Yu Shu Min, Mr. Lin Lan, Mr. Xiao Jian Lin and Ms. Liu Chun Xin; and the Company’s independent non-executive directors are Mr. Zhang Sheng Ping, Mr. Cheung Yui Kai, Warren and Mr. Wang Ai Guo.

Foshan City, Guangdong, the PRC, 10 August 2011

2